Viewing Study NCT06390059


Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2025-12-25 @ 11:53 PM
Study NCT ID: NCT06390059
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-30
First Post: 2024-02-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor: NovoCure Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module